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Abstract The binding of three iniluenza A and one influenza B virus strains to proteins of three continuously cultured cell lines was studied using 
protein overlay and immunostaining methods. The results obtained indicated the presence of both sialic acid-dependent and -independent binding 
of the virus strains; virus binding to proteins in the molecular mass range from about 40 to 103 kDa was dependent on sialic acid, whereas binding 
to the 33 kDa protein was independent of sialic acid. The 33 kDa binding protein was identified as nnexin, a widely distributed non-glycosylated 
calcium-dependent phospholipid-binding protein. 
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1. Introdnetlon 
The first step in a virus infection is the recognition of cell 
surface receptors by the virus. The receptor of influenza viruses 
is known to be sialic acid (N-acetylneuraminic acid), which is 
linked to the oligosaccharide side chains of glycolipids and 
glycoproteins [1,2]. Sialic acid is needed for the initial attach- 
ment of the virus to the host cell surface. This step is mediated 
by the hemagglutinin of the viral membrane. Sialic acid is 
bound to the hemagglutinin fragment HAl, while the hemag- 
glutinin fragment HA2 is thought to mediate the fusion be- 
tween viral and cellular membranes [2-51. The fusion step, a 
prerequisite for virus entry, is strongly inhibited by certain 
phospholipids and glycolipids [6], presumably because they 
compete with membrane lipids involved in the fusion process. 
Thus, cell penetration by these viruses appears to depend on 
a sequence of linked reaction steps. It is possible that other, as 
yet unknown reactions, may also be involved in this sequence 
of events. 
Information on virus-cell interactions can be obtained by 
screening cell membrane components for their ability to bind 
the virus. Gershoni et al. developed an overlay method to detect 
proteins of the erythrocyte membrane that can bind to Sendai 
virus [7j. We have used this method and immunostaining tech- 
niques to localize cellular proteins that can interact with influ- 
enza viruses. It was shown that three continuous cell lines, 
MDCK, BHK and HeLa cells, contain both sialic acid-depend- 
ent and -independent binding proteins for influenza viruses. 
This report concentrates on a sialic acid-independent virus- 
binding protein, 33 kDa annexin. This non-glycosylated protein 
is a member of the ubiquitous annexin family that has been 
shown to possess a variety of important cellular functions such 
as calcium and phospholipid binding [g-13], signal transduction 
[ 141, and regulation of cell proliferation [ 151. That annexin can 
also bind viruses is a novel facet of its many biological roles. 
2. Experimental 
2.1. Cells and viruses 
Continuous cell lines of MDCK (Madin Darby canine kidney) cells, 
*Corresponding author. Fax: (49) (30) 838 4802. 
BHK (baby hamster kidney) cells and HeLa cells were grown to conllu- 
ency in Dulbecco’s medium and used for protein separation and blot- 
ting. Human erythrocyte ghosts were prepared according to Fairbanks 
et al. [16]. 
2.2. I&uses and purification 
Three influenza A viruses, fowl plague virus (FPV A/Restock; 
HavlNl), PR8 (A/PR/8/34; HONl) and Singapore (A/Singapore/6/86; 
Hl,Nl) as well as one influenza B viNS (B/Nunagata/l6/88) were used. 
Viruses were propagated in the allantoic avity of 1 l-day-old embryon- 
ated eggs. The allantoic fluid containing the viruses were harvested and 
purified on sucrose gradients according to Klenk et al. [17]. 
2.3. Virus labelling with (“C]amino acia5 orjluorescein isothionate 
(FITC) 
Viruses were grown in MDCK or BHK cells, collected from culture 
medium and purified on sucrose gradients according to Klenk et al. [17J. 
For radioactive labelling, amixture of L-[“Qunino acids were included 
in the medium at a concentration of 800 kBq/ml during the period of 
3-10 pi. Vises were then harvested at 10p.i., pelleted by centrifuga- 
tion at 20,000 x g for 60 min and purified on sucrose gradients as above. 
Purified virus concentrates containing a hemagglutinating unit of 
128,OOO/ml were used for fluorescein labelling essentially according to 
Fomi [ 181. Fluorescein-labelled viruses were found to retain all of their 
hemagglutinating activity. 
2.4. Polyacrylamide gel electrophoresb lotting and overlay of viruses 
on protein blots 
MDCK, BHK and HeLa cells grown to confluency were washed with 
saline and harvested by a rubber policeman and processed further for 
SDS-PAGE as described by Laemmli [19]. Slab gels were blotted onto 
nitrocellulose filters (Scheicher & Schu& BA 83, 0.2 pm, no. 401396) 
as described by Gershoni et al. [7l, using a Mini Tram-Blot apparatus 
(Bio-Rad). 
Protein blots were treated with block solution (PBS containing 1% 
bovine serum albumin and 1% polyvinyl pyrrolidone) for 2 h at room 
temperature. The blots were washed with PBS and incubated with virus 
suspensions containing 1024 hemagglutinating units/ml at 4°C over- 
night. The blots were washed and air dried. In the case of “C-labelled 
viruses, virus binding was detected by autoradiography using Kodak 
X-OMAT AR film. In the case of fluorescein-labelled viruses, bound 
viruses were detected directly in a chamber equipped with a multi- 
wavelength illuminator. 
2.5. Monoclonal antibodies and immunostaining 
Monoclonal antibody against the hemagglutinin fragment HA1 of 
FPV was kindly supplied by Dr. H. Becht of the Institute of Virology, 
Justus-Liebig Universitiit, Giessen. This antibody was produced and 
characterized as previously described [20]. Monoclonal antibody 
against annexin 33 kDa was supplied by Dr. Lii of our Institute [21]. 
Protein blots overlayed with FPV as described above were immersed 
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in a 1:400 diluted monoclonal anti-FPV antibody solution for 2 h at 
4°C. The sheets were washed five times with PBS and treated once with 
block solution for 30 min, then incubated with a 1: 1000 diluted perox- 
idase-coupled anti-mouse IgG (Sigma cat. no. A9044) for 2 h at room 
temperature. The general procedure was basically as described by Ger- 
shoni et al. [7l. Inununodetection f annexin 33 kDa was performed 
similarly as above. 
2.6. Miscellaneous 
Cells harvested from monolayers with rubber policeman and sus- 
pended in physiological saline were treated with 0.1 unit of neuram- 
inidase from V7brio cholerae (Behringwerke, Germany) for 2 h at 37°C 
in a total volume of 1 ml prior to electrophoresis. Protein blots were 
also treated with neuraminidase in the same manner. 
Periodate oxidation was performed on protein blots in a 0.1 M 
sodium periodate solution for 2 h at room temperature in a similar way 
as described by Suttajit and Winzler [22]. 
Dansyl phosphatidylethanolamine was prepared by reacting acom- 
mercially available phosphatidylethanol (Sigma cat. no. P5149) 
with dansyl chloride in the same manner as that described for synthesis 
of da.nsyl cerebroside [23]. Dansyl phosphatidylethanolamine was dis- 
solved in PBS at a concentration of 1 &nl by a brief ultrasonic 
treatment. 
3. Results and discussion 
SDS-PAGE of the proteins (Fig. 1A) of MDCK (lanes 1,2), 
BHK (lanes 3,4), HeLa (lanes 6,7) cells and erythrocytes (lanes 
8,9) produces complicated patterns. As can be seen from this 
figure, protein patterns of the same cells are not different when 
the cells have been pretreated with the neuraminidase of Vibrio 
cholerae before electrophoresis (Fig. lA, lanes 2, 4, 7 and 9). 
However, when these protein patterns were blotted onto nitro- 
cellulose, then overlayed with “C-labelled influenza virus 
strains FPV and PR 8, it was found that the viruses were bound 
to different proteins. Fig. lB, C, lanes 1, 3, 6 and 8 show the 
patterns of virus-binding when cells have not been treated with 
the neuraminidase: generally, FPV and PR 8 were bound differ- 
ently to proteins of 35, 92 and 103 kDa and to fast moving 
compounds near the gel front. However, both viruses were 
equally bound to the 30 and 33 kDa proteins in all cultured cell 
lines. When erythrocyte proteins were used, both viruses bound 
only to the higher molecular mass proteins (Fig. lB, C, lane 8). 
Binding patterns were altered by treatment of cells with the 
neuraminidase (Fig. lB, C, lanes 2,4 and 7); the high molecular 
mass proteins in the 90 kDa range were no longer able to bind 
the viruses, whereas binding to the 30 and 33 kDa proteins was 
retained by both FPV and PR 8. The same results were ob- 
served after destruction of sialic acid on the blot with periodate 
(not shown). These results showed that the binding to the 30 
and 33 kDa proteins is independent of sialic acid. In similar 
studies with proteins from erythrocytes, the removal of sialic 
acid with neuraminidase resulted in the abolition of all virus 
binding (Fig. lB, C, lane 9). Sialic acid is therefore an essential 
constituent of all virus-binding proteins of erythrocytes. 
Another experiment was performed with the B/Yamagata 
strain that had been prelabelled with fluorescein. The fluoro- 
grams of virus binding are shown on Fig. 2. As in the previous 
case, the virus bound to proteins in the high molecular mass 
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Fig. 2. Overlay of FITC-labelled virus (BIyamagata) on protein blots 
of BHK cells. Lane 1, marker proteins; in lane 2 the blot was untreated 
and in lane 3 the blot was treated with neuraminidase prior to overlay 
with virus. 
range, as well as to the 33 kDa protein before neuraminidase 
treatment (Fig. 2, lane 2). After neuraminidase treatment, only 
the 33 kDa protein remained bound to the virus (Fig. 2, lane 
3). Virus binding to the 35 kDa protein and other fast moving 
compounds were not observed in this case. 
In another experiment using immunoblotting for the detec- 
tion of virus binding, influenza virus strain FPV was found to 
bind to several high molecular mass protein bands as well as 
to the 33 kDa protein and some fast moving compounds (Fig. 
3A, lane 2). After treatment of the protein blots with neuram- 
inidase, only the 33 kDa protein remained capable of binding 
the virus (Fig. 3A, lane 3). Thus the 33 kDa protein was again 
found to be the common component of the cells that bound the 
viruses in a sialic acid-independent manner. To identity this 
sialic acid-independent virus-binding protein of 33 kDa, we 
compared it with other widely distributed proteins of the same 
molecular mass. It was found that one of such proteins, 33 kDa 
annexin, was stained exactly at this position in a Western blot, 
using a monoclonal antibody against this protein (Fig. 3A, 
lane 4). 
t 
Fig. 1. Total proteins (A) of cultured cells and positions of virus binding for FPV (B) and PR8 (C) strains on nitrocellulose blots of these proteins. 
MDCK (lanes 1, 2), BHK (lanes 3, 4), HeLa (lanes 6, 7) cells and human erythrocyte ghosts (lanes 8, 9); lanes 1, 3, 6 and 8 are from cells that had 
not been treated with neuraminidase prior to SDS-PAGE; lane 5 is a molecular weight standard mixture, showing, from top to bottom, 66,45, 36, 
29, 24, 20 and 14 kDa. 
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Fig. 3. Binding patterns of FPV, 33 kDa annex& dansylphosphatidylethanolamin and A/Singapore on protein blots of BHK cells. (A) Immnnostain- 
ing: lane 1, marker protein, lane 2, FPV overlaid on blot of BHK cell proteins; lane 3, FPV overlaid on blot of BHK cell proteins pretreated with 
nenraminidase; lane 4, overlay of 33 kDa annexin on BHK cell protein blot. (B) Fluorogram: lane 1, marker protein; lane 2, dansylphosphatidyl- 
ethanolamin; lane 3, overlay of A/Singapore on blot; lane 4, overlay of A/Singapore on blot pretreated with monoelonal antibody against 33 kDa 
annexin. 
From the following additional evidence, using fluorescein- 
lahelled virus (A/Singapore), the 33 kDa virus-binding protein 
was conclusively identified as 33 kDa annexin, a family of 
phospholipid binding proteins. First, dansyl phosphatidyletha- 
nolamine, a fluorescence-labelled phospholipid, was shown to 
he bound exactly to the 33 kDa position (Fig. 3B, lane 2). 
Second, this position corresponds to that of the 33 kDa virus- 
binding protein detected by fluorescence-labelled virus (Fig. 
3B, lane 3). Third, protein blots pretreated with the monoclonal 
antibody against 33 kDa annexin lost the ability to bind the 
viruses at the 33 kDa position while retaining the virus binding 
in the higher molecular mass range (Fig. 3B, lane 4), showing 
that free, unbound annexin is necessary for virus binding. 
The above tindings are surprising because sialic acid is gener- 
ally considered to be the only cellular receptor of influenza 
viruses [1,2]. Influenza viruses possess densely packed 
glycoprotein spikes extending from the lipid bilayer which con- 
tains phospholipids. Some bending or compression of the 
spikes during virus attachment o the cell might make the 
phospholipids accessible to 33 kDa annexin. In this way, virus 
binding can then occur independently of sialic acid. It is possi- 
ble that 33 kDa annexin of the plasma membrane can function 
as a ‘second’ receptor to enable infection of influenza viruses 
that are detached from the ‘first’ receptor, sialic acid, by the 
viral neuraminidase. In contrary, it is also possible that virus 
binding to annexin is a mechanism used by cells to fend off virus 
infection: virus that binds to annexin may be immobilized on 
the plasma membrane and thereby prevented from entering the 
cell. Thus, the consequence of virus binding to 33 kDa annexin 
can be either promotion or inhibition of infection, depending 
on which of the above mechanisms is operating. 
33 kDa annexin may be of interest as a binding protein for 
enveloped viruses in general. It is noteworthy that the same 
technique has revealed the presence, in several cell lines, of 
30-35 kDa binding proteins for a number of unrelated envel- 
oped viruses. A recent study reported the binding of human 
cytomegalovirus to two proteins belonging to lymphocyte and 
fibroblast cell membranes. Their molecular masses were esti- 
mated to be 32 and 34 kDa [24]. Similarly, proteins with molec- 
ular masses between 30 and 33 kDa have recently been identi- 
fied as putative receptors for the visna virus [25]. These binding 
proteins have not been characterized in detail, but because of 
the closeness of the reported molecular masses and their com- 
mon ability to bind phospholipid-containing enveloped viruses, 
some of these may well be the same 33 kDa annexin described 
in the present study. What role annexin plays in the infection 
of these viruses is of great interest for further studies. 
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